Abstract:(1) Background: Toad venom (Bufonis Venenum, known as 'Chansu' in Chinese), the secretion of the ear-side gland and skin gland of Bufo gargarizans cantor or Duttaphrynus melanostictus Schneider, has been utilized to treat several diseases in China for thousands of years. However, due to the chemical variability of the components, systematic chemical composition and the key pharmacophores in toad venom have not yet fully understood. Besides, it contains a variety of effective compounds with different physiological activity and chemotypes, mainly including alkaloids, bufogenins, bufotoxins, and so on. The recent pharmacological researches have demonstrated that several bufogenins have remarkable pharmacological effects, such as anti-inflammatory, analgesic effects, and anti-tumor effects. Aim of the study: To identify the bioactive compounds and pharmacophores originating from toad venom based on analyzing spectrum-effect relationship by chemometrics and to explore the anti-cancer mechanism primarily. (2) Materials and methods: Fingerprint of the 21 batches of samples was established using HPLC (High Performance Liquid Chromatography). The anti-tumor activity of extracts were determined by in-vitro assays. Chemometric analysis was used to establish the spectrum-effect model and screen for active ingredients. Pharmacodynamic tests for the screened active compound monomers were conducted with in-vitro assays. Further anti-tumor mechanisms were investigated using western blot and flow cytometry. (3) Results: The established spectrum-effect model has satisfactory fitting effect and predicting accuracy. The inhibitory effect of major screened compounds on lung carcinoma cells A549 were validated in vitro, demonstrating that arenobufagin, telocinobufogenin, and cinobufotalin had significant anti-tumor effects. Through further investigation of the mechanism by western blotting and flow cytometry, we elucidated that arenobufagin induces apoptosis in A549 cells with the enhanced expression of cleaved PARP (poly (ADP-ribose) polymerase). These results may provide valuable information for further structural modification of bufadienolides to treat lung cancer and a method for discovery of anti-tumor active compounds. Conclusions: Our research offers a more scientific method for screening the principal ingredients dominating the pharmacodynamic function. These screened compounds (arenobufagin, etc.) were proven to induce apoptosis by overactivation of the PARP-pathway, which may be utilized to make BRCA (breast cancer susceptibility gene) mutant cancer cells more vulnerable to DNA damaging agents and kill them.

Microbial Transformation of Three Bufadienolides by Nocardia Sp. and Some Insight for the Cytotoxic Structure–activity Relationship (SAR)

Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships.

New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

Biotransformation of Bufadienolides by Cell Suspension Cultures of Saussurea Involucrata

ChemInform Abstract: Microbial Transformation of Three Bufadienolides by Nocardia Sp. and Some Insight for the Cytotoxic Structure—Activity Relationship (SAR).

Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani

New Cytotoxic 19-Norbufadienolide and Bufogargarizin Isolated from Chan Su

Microbial Transformation of Bufotalin by Alternaria Alternata As 3.4578

Structurally diverse bufadienolides from the skins of Bufo bufo gargarizans and their cytotoxicity

Aurovertin‐Type Polyketides from Calcarisporium Arbuscula with Potent Cytotoxic Activities Against Triple‐Negative Breast Cancer

Microbial transformation of three bufadienolides by Penicillium aurantigriseum and its application for metabolite identification in rat

Enzymatic Synthesis of Bufadienolide O‐Glycosides as Potent Antitumor Agents Using a Microbial Glycosyltransferase

Biotransformation of arenobufagin and cinobufotalin by Alternaria alternata

Microbial Hydroxylation of Bufalin by Cunninghamella Blakesleana and Mucor Spinosus.

Microbial transformation of cinobufagin by Syncephalastrum racemosum.

Identification of Antitumor Constituents in Toad Venom by Spectrum-Effect Relationship Analysis and Investigation on Its Pharmacologic Mechanism

Cytochrome P450 Mining for Bufadienolide Diversification

Cytotoxic Resibufogenin Transformation Products from Cell Suspension Cultures of Platycodon Grandiflorum

Biotransformation of Cinobufagin by Cell Suspension Cultures of Catharanthus Roseus and Platycodon Grandiflorum

3α-Hydroxybufadienolides in Bufo gallbladders: structural insights and biotransformation

Synthesis and Structure–activity Relationships Study of Cytotoxic Bufalin 3-Nitrogen-containing-ester Derivatives